Annual CFI
-$19.00 K
+$28.00 K+59.57%
December 31, 2023
Summary
- As of February 7, 2025, ERNA annual cash flow from investing activities is -$19.00 thousand, with the most recent change of +$28.00 thousand (+59.57%) on December 31, 2023.
- During the last 3 years, ERNA annual CFI has risen by +$20.00 thousand (+51.28%).
- ERNA annual CFI is now at all-time high.
Performance
ERNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$19.00 K
+$230.00 K+92.37%
September 30, 2024
Summary
- As of February 7, 2025, ERNA quarterly cash flow from investing activities is -$19.00 thousand, with the most recent change of +$230.00 thousand (+92.37%) on September 30, 2024.
- Over the past year, ERNA quarterly CFI has stayed the same.
- ERNA quarterly CFI is now -107.12% below its all-time high of $267.00 thousand, reached on March 1, 2021.
Performance
ERNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$384.00 K
-$19.00 K-5.21%
September 30, 2024
Summary
- As of February 7, 2025, ERNA TTM cash flow from investing activities is -$384.00 thousand, with the most recent change of -$19.00 thousand (-5.21%) on September 30, 2024.
- Over the past year, ERNA TTM CFI has dropped by -$365.00 thousand (-1921.05%).
- ERNA TTM CFI is now -251.66% below its all-time high of $253.20 thousand, reached on June 1, 2021.
Performance
ERNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ERNA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.6% | 0.0% | -1921.0% |
| 3 y3 years | +51.3% | -100.0% | -10000.0% |
| 5 y5 years | +51.3% | -100.0% | -10000.0% |
ERNA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.9% | -114.7% | +92.4% | -397.7% | +98.3% |
| 5 y | 5-year | at high | +99.9% | -107.1% | +99.9% | -251.7% | +98.3% |
| alltime | all time | at high | +99.9% | -107.1% | +99.9% | -251.7% | +98.3% |
Eterna Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.00 K(-92.4%) | -$384.00 K(+5.2%) |
| Jun 2024 | - | -$249.00 K(+156.7%) | -$365.00 K(+214.7%) |
| Mar 2024 | - | -$97.00 K(+410.5%) | -$116.00 K(+510.5%) |
| Dec 2023 | -$19.00 K(-59.6%) | -$19.00 K(<-9900.0%) | -$19.00 K(-114.7%) |
| Sep 2023 | - | $0.00(0.0%) | $129.00 K(+50.0%) |
| Jun 2023 | - | $0.00(0.0%) | $86.00 K(-8700.0%) |
| Mar 2023 | - | $0.00(-100.0%) | -$1000.00(-97.9%) |
| Dec 2022 | -$47.00 K | $129.00 K(-400.0%) | -$47.00 K(-85.4%) |
| Sep 2022 | - | -$43.00 K(-50.6%) | -$323.00 K(-98.6%) |
| Jun 2022 | - | -$87.00 K(+89.1%) | -$23.14 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$46.00 K(-68.7%) | -$23.05 M(+1.4%) |
| Dec 2021 | -$22.74 M(>+9900.0%) | - | - |
| Dec 2021 | - | -$147.00 K(-99.4%) | -$22.74 M(+0.6%) |
| Sep 2021 | - | -$22.86 M(>+9900.0%) | -$22.61 M(-9028.8%) |
| Jun 2021 | - | -$1000.00(-100.4%) | $253.20 K(+8.9%) |
| Mar 2021 | - | $267.00 K(-2185.9%) | $232.50 K(-696.2%) |
| Dec 2020 | -$39.00 K | -$12.80 K(<-9900.0%) | -$39.00 K(+48.9%) |
| Sep 2020 | - | $0.00(-100.0%) | -$26.20 K(0.0%) |
| Jun 2020 | - | -$21.70 K(+382.2%) | -$26.20 K(+482.2%) |
| Mar 2020 | - | -$4500.00 | -$4500.00 |
FAQ
- What is Eterna Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Eterna Therapeutics?
- What is Eterna Therapeutics annual CFI year-on-year change?
- What is Eterna Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly CFI year-on-year change?
- What is Eterna Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Eterna Therapeutics?
- What is Eterna Therapeutics TTM CFI year-on-year change?
What is Eterna Therapeutics annual cash flow from investing activities?
The current annual CFI of ERNA is -$19.00 K
What is the all time high annual CFI for Eterna Therapeutics?
Eterna Therapeutics all-time high annual cash flow from investing activities is -$19.00 K
What is Eterna Therapeutics annual CFI year-on-year change?
Over the past year, ERNA annual cash flow from investing activities has changed by +$28.00 K (+59.57%)
What is Eterna Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ERNA is -$19.00 K
What is the all time high quarterly CFI for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly cash flow from investing activities is $267.00 K
What is Eterna Therapeutics quarterly CFI year-on-year change?
Over the past year, ERNA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Eterna Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ERNA is -$384.00 K
What is the all time high TTM CFI for Eterna Therapeutics?
Eterna Therapeutics all-time high TTM cash flow from investing activities is $253.20 K
What is Eterna Therapeutics TTM CFI year-on-year change?
Over the past year, ERNA TTM cash flow from investing activities has changed by -$365.00 K (-1921.05%)